Invention Grant
- Patent Title: Light single-chain fusion polypeptides, encoding nucleic acid molecules and host cells
-
Application No.: US16832183Application Date: 2020-03-27
-
Publication No.: US11214605B2Publication Date: 2022-01-04
- Inventor: Oliver Hill , Christian Gieffers , Meinolf Thiemann
- Applicant: APOGENIX AG
- Applicant Address: DE Heidelberg
- Assignee: APOGENIX AG
- Current Assignee: APOGENIX AG
- Current Assignee Address: DE Heidelberg
- Agency: Perkins Coie LLP
- Agent Viola T. Kung
- Priority: EP08013112 20080721
- Main IPC: C12N15/62
- IPC: C12N15/62 ; C12N15/79 ; C07K14/705 ; C07K14/525 ; C07K16/00 ; A61K38/00
Abstract:
The present invention refers to single-chain fusion proteins comprising three soluble TNF superfamily (TNFSF) cytokine domains and nucleic acid molecules encoding these fusion proteins. The fusion proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.
Public/Granted literature
- US20200247860A1 LIGHT SINGLE CHAIN MOLECULES Public/Granted day:2020-08-06
Information query
IPC分类:
